“…Peptide self-assembled nanoplatforms based on a "bottom-up" assembly approach have been widely used for precise target and targeted therapy. [64][65][66][67] Various nanostructures of self-assembled peptide materials, such as hydrogels, [68][69][70][71] lipid-like vesicles, 72 and nanofibers, [73][74][75] are ideal candidates for being developed into drug carriers due to their superb packaging ability, safety protection, and precise drug release. Compared to other traditional nano-drug systems, the main advantage of peptide scaffold-based smart nano-drug systems is that they can respond to multi-layered stimuli in vivo, such as microenvironmental stimuli, cellular stimuli (e.g., pH, 76 ionic strength, [77][78][79] receptor-ligand interactions, [80][81][82] specific proteins, 83 or enzymes 84,85 ), and external environmental stimuli (e.g., light, 86 temperature, 87 ultrasound, 88 electric, 89 or magnetic fields 90 ), and can mediate controlled drug release in situ.…”